Research Tracker›Biomarker Atlas›ME/CFS›Muscarinic cholinergic autoantibodies

Muscarinic cholinergic autoantibodies in ME/CFS

Muscarinic cholinergic autoantibodies, also described as Anti-M3/M4, belongs to the autoimmune group of ME/CFS (ME/CFS, CFS) markers and is reported to be raised relative to healthy controls. The cited literature links this alteration to autonomic, GI symptoms. The evidence summarised here comes from Maksoud et al. 2023 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedAutoimmune

Summary

Direction in ME/CFS↑ Elevated — higher than in the comparison group
CategoryAutoimmune
Also described asAnti-M3/M4
Compared againstHC (healthy controls)
Associated symptomsAutonomic, GI symptoms
Test typeBlood test (serum / plasma / whole blood)
SourceMaksoud et al. 2023 — doi:10.1186/s12916-023-02893-9
Condition atlasME/CFS Biomarker Atlas

Related Autoimmune markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is Muscarinic cholinergic autoantibodies high or low in ME/CFS?

Elevated. Studies summarised in the OSMF atlas report higher Muscarinic cholinergic autoantibodies in ME/CFS than in healthy controls. Source: Maksoud et al. 2023.

What symptoms is Muscarinic cholinergic autoantibodies associated with in ME/CFS?

The cited literature associates this marker with Autonomic, GI symptoms. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Muscarinic cholinergic autoantibodies?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Muscarinic cholinergic autoantibodies result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. Muscarinic cholinergic autoantibodies findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Muscarinic cholinergic autoantibodies in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/muscarinic-cholinergic-autoantibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.